- Pelle MT, Callen JP. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol. 2002;138(9):1231–1233; discussion 1233. doi:10.1001/archderm.138.9.1231.
- Ge Y, Lu X, Shu X, Peng Q, Wang G. Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts. Sci Rep. 2017;7(1):188. doi:10.1038/s41598-017-00240-6.
- Waldman R, DeWane ME, Lu J. Dermatomyositis: diagnosis and treatment. J Am Acad Dermatol. 2020;82(2):283–296. doi:10.1016/j.jaad.2019.05.105.
- Okiyama N, Fujimoto M. Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies. F1000Res. 2019;8:1951. doi:10.12688/f1000research.20646.1.
- Jia E, Wei J, Geng H, et al. Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review. Clin Rheumatol. 2019;38(8):2189–2193. doi:10.1007/s10067-019-04562-w.
- Albayda J, Mecoli C, Casciola-Rosen L, et al. A North American cohort of anti-SAE dermatomyositis: clinical phenotype, testing, and review of cases. ACR Open Rheumatol. 2021;3(5):287–294. doi:10.1002/acr2.11247.
- Wolstencroft PW, Casciola-Rosen L, Fiorentino DF. Association between autoantibody phenotype and cutaneous adverse reactions to hydroxychloroquine in dermatomyositis. JAMA Dermatol. 2018;154(10):1199–1203. doi:10.1001/jamadermatol.2018.2549.
- Sharma AN, Mesinkovska NA, Paravar T. Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review. J Am Acad Dermatol. 2020;83(2):563–578. doi:10.1016/j.jaad.2020.04.024.
- Muro Y, Sugiura K, Nara M, Sakamoto I, Suzuki N, Akiyama M. High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis. Rheumatology (Oxford). 2015;54(9):1745–1747. doi:10.1093/rheumatology/kev247.
- Marie I, Guillevin L, Menard JF, et al. Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev. 2012;11(9):615–620. doi:10.1016/j.autrev.2011.10.024.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 1
Clinician’s Corner
Adverse cutaneous reaction to hydroxychloroquine in a patient with anti-SAE-1-positive dermatomyositis and a history of diffuse large B-cell lymphoma
, MD, 
, , BS & , MD
Soumya A. Reddyb School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USACorrespondence[email protected]
https://orcid.org/0000-0003-2558-1668
, BSAhttps://orcid.org/0000-0003-2558-1668, , BS & , MD